FIELD: medicine.
SUBSTANCE: invention relates to application of recombinant antibody having hypervariable sites of CDR region with specific amino acid sequence for treatment and preventing of non-specific ulcer colitis and Crone disease in steroid-resistant patients.
EFFECT: improved preparation for treatment of steroid-resistant patients.
15 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF CD-25-BINDING MOLECULES FOR TREATING INFLAMMATORY DISEASES OF GASTROINTESTINAL TRACT | 2001 |
|
RU2286797C2 |
| RECOMBINED ANTIBODY TO HUMAN INTERLEUKIN 1β | 2001 |
|
RU2264413C2 |
| HUMAN ANTIBODIES TO IL-β1 | 2001 |
|
RU2286351C2 |
| METHOD FOR TREATMENT OF PEDIATRIC DISORDERS/DISEASES | 2018 |
|
RU2778567C2 |
| DRUGS FOR TREATING DISEASES | 2010 |
|
RU2598719C2 |
| METHODS OF TREATING CHRONIC POUCH ILEITIS | 2018 |
|
RU2822135C2 |
| ANTIBODIES RAISED TO HUMAN MCP-1 | 2001 |
|
RU2314316C2 |
| NEW INDICATIONS FOR USE IN TREATING ANTIBODIES AGAINST IL-1-BETA | 2014 |
|
RU2698208C2 |
| NOVEL APPLICATION OF IL-1β COMPOUNDS | 2012 |
|
RU2571563C2 |
| THERAPEUTIC BINDING MOLECULES | 2002 |
|
RU2328506C2 |
